Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples

Fig. 2

MiR-30a-5p promoter methylation levels, miR-30a-5p expression levels, and prognostic value in Cohort #1. a Scatter plots representing relative miR-30a-5pme and expression levels between RNT (n = 25) and ccRCC (n = 226) samples (Mann–Whitney U test); b Disease-free and c disease-specific Kaplan-Meier survival curves based on miR-30a-5pme and expression levels (Log-rank test)

Back to article page